Horizon Therapeutics announces acquisition by Amgen approved in Ireland
PremiumThe FlyHorizon Therapeutics announces acquisition by Amgen approved in Ireland
1y ago
Larimar Therapeutics appoints Horizon Therapeutics CMO Jeffrey Sherman to board
Premium
The Fly
Larimar Therapeutics appoints Horizon Therapeutics CMO Jeffrey Sherman to board
1y ago
Horizon Therapeutics announces new data on TEPEZZA treatment
Premium
The Fly
Horizon Therapeutics announces new data on TEPEZZA treatment
1y ago
Amgen, Horizon Therapeutics confirm resolution of FTC lawsuit
PremiumThe FlyAmgen, Horizon Therapeutics confirm resolution of FTC lawsuit
1y ago
Amgen to settle FTC and state challenges to Horizon Therapeutics takeover
Premium
The Fly
Amgen to settle FTC and state challenges to Horizon Therapeutics takeover
1y ago
Amgen reaches settlement with FTC on Horizon Therapeutics takeover
Premium
The Fly
Amgen reaches settlement with FTC on Horizon Therapeutics takeover
1y ago
Viridian Therapeutics price target lowered to $39 from $46 at Wells Fargo
PremiumThe FlyViridian Therapeutics price target lowered to $39 from $46 at Wells Fargo
1y ago
Horizon Therapeutics reports Q2 EPS $1.20, consensus $1.11
Premium
The Fly
Horizon Therapeutics reports Q2 EPS $1.20, consensus $1.11
1y ago
HZNP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
HZNP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100